Your English writing platform
Discover LudwigSuggestions(2)
Exact(1)
Despite early skepticism, increasing evidence shows that in vitro macrolide resistance does result in clinical and microbiologic failures in systemic pneumococcal infection (22, 23 ).
Similar(59)
We evaluated the superiority of directly observed therapy (DOT) for tuberculosis patients vs self-administered therapy (SAT) in decreasing ADR, microbiologic failure, and relapse in meta-analyses.
Conclusions DOT was not significantly better than SAT in preventing microbiologic failure, relapse, or ADR, in evidence-based medicine.
b Among those in whom microbiologic failure occurred, two of three patients in the anidulafungin group and eight of nine in the fluconazole group had persistent infection.
Endpoints were microbiologic failure, relapse, and ADR in patients on either DOT or SAT.
The other two patients in whom microbiologic failure occurred had superinfections.
The use of broad spectrum antibiotics as the initial management of suspected VAP is likely to result in less microbiologic failure and improved clinical outcomes.
In subgroup analysis, microbiologic failure for rural/urban studies was significantly higher on DOT compared to SAT (P =.045).
We performed a meta-analysis of prospective studies to compare microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients on directly observed versus self-administered therapy.
The association is also important to recognize as it suggests that interruptions in therapy have implications that go beyond recognized increases in risk for microbiologic failure, relapse of disease or even development of drug resistance.
There was no significant change in effect size for microbiologic failure or ADR or relapse, for all (Supplementary Figures 2 4).
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com